Dr. Raghavan Venugopal
Director of Imaging and Algorithms at Roche

Bio: Raghavan is currently the Head of Imaging and Algorithms at Roche Tissue Diagnostics. He is responsible for a team of Image Analysis Scientists and Software Engineers that build quantitative algorithms using AI techniques to build commercial DP algorithms for clinical use and also help various internal Roche collaborators/partners create new assays, drugs and conduct research.

Prior to joining Roche, Raghavan was the Director of Engineering at First Insight, a Pittsburgh based company that uses consumer data and predictive data analytics to inform retailers on what products will do well in the market place and how to price them accordingly. Prior to that, he was the Vice President of Product Management at Inspirata Inc. Raghavan also worked at GE Healthcare (Omnyx LLC) as a Senior Software Manager for Digital Pathology Solutions. He has a combined 20 years’ experience in Digital Pathology, Cardiovascular applications, Toll systems, Semiconductors and Retail.

Raghavan has an MS in Electrical Engineering from Clemson University and Bachelors in Electronics Engineering from University of Mumbai.



  Prof. Zhu Hongguang
Vice President of Chinese Society of Pathology

Bio: Prof. Zhu Hongguang obtained his Ph.D from Shanghai Medical University (currently Shanghai Medical College of Fudan University), worked as a postdoctoral scientist with Max Planck Gesellschaft in Germany, and worked at the Robert Wood Johnson Medical School of Rutgers University as a visiting professor. He is currently Vice President of Chinese Society of Pathology with Chinese Medical Association, Chairman of the Department of Pathology of School of Basic Medical Sciences of Fudan University, professor with the Department of Pathology of Huashan Hospital, Board Member of the Pathology Committee of Shanghai Medical Association, Deputy Editor in Chief with Chinese Journal of Pathology, and council member of Shanghai Medical Association.
His research interests include hepatopathy pathology, tumor biomarkers, tumor molecular pathology, and surgical pathological diagnosis. He is in charge of several projects sponsored by National Natural Science Foundation of China and Shanghai Province. He has won the second prize of Shanghai Science and Technology Progress Awards and the third prize of the Fifth National Youth Science and Technology Forum. He is in charge of a major project sponsored by Shanghai Municipal Science and Technology Commission with a total funding of 2,200,000 RMB. He also participates as sub-project leader in one project sponsored by National High Technology Research and Development Program (Program 863) of China, one general project and one key project sponsored by National Natural Science Foundation of China.
He has published over 30 papers on SCI journals.